SUPPLEMENT

Q3 2024 — Financial statement information

Q3 2024PDF · 17 pages354 KB
Three months ended
September 30,
Nine months ended
September 30,
2024 2023 2024 2023
Net sales $ 6,294 $ 6,270 $ 18,565 $ 18,608
Operating expenses
Cost of sales 3,647 3,716 10,703 11,188
Selling, general and administrative expenses 1,062 5,419 3,322 18,182
Research, development and related expenses 269 267 803 862
Gain on business divestitures — (36) — (36)
Total operating expenses 4,978 9,366 14,828 30,196
Operating income (loss) 1,316 (3,096) 3,737 (11,588)
Other expense (income), net (405) 206 (323) 334
Income (loss) from continuing operations before income taxes 1,721 (3,302) 4,060 (11,922)
Provision (benefit) for income taxes 348 (777) 771 (2,893)
Income (loss) from continuing operations of consolidated group 1,373 (2,525) 3,289 (9,029)
Income (loss) from unconsolidated subsidiaries, net of taxes 3 2 7 7
Net income (loss) from continuing operations including noncontrolling
interest 1,376 (2,523) 3,296 (9,022)
Less: Net income (loss) attributable to noncontrolling interest 4 4 15 14
Net income (loss) from continuing operations attributable to 3M 1,372 (2,527) 3,281 (9,036)
Net income (loss) from discontinued operations, net of taxes — 452 164 1,096
Net income (loss) attributable to 3M $ 1,372 $ (2,075) $ 3,445 $ (7,940)
Earnings (loss) per share attributable to 3M common shareholders:
Weighted average 3M common shares outstanding — basic 550.6 554.3 553.1 553.7
Earnings (loss) per share from continuing operations — basic $ 2.49 $ (4.56) $ 5.93 $ (16.32)
Earnings (loss) per share from discontinued operations — basic — 0.82 0.30 1.98
Earnings (loss) per share — basic $ 2.49 $ (3.74) $ 6.23 $ (14.34)
Weighted average 3M common shares outstanding — diluted 552.7 554.3 554.5 553.7
Earnings (loss) per share from continuing operations — diluted $ 2.48 $ (4.56) $ 5.92 $ (16.32)
Earnings (loss) per share from discontinued operations — diluted — 0.82 0.29 1.98
Earnings (loss) per share — diluted $ 2.48 $ (3.74) $ 6.21 $ (14.34)
3M Company and Subsidiaries
CONSOLIDATED STATEMENT OF INCOME (LOSS)
(Millions, except per-share amounts)
(Unaudited)
1

-- 1 of 17 --

September 30, 2024 December 31, 2023
ASSETS
Current assets
Cash and cash equivalents $ 6,050 $ 5,735
Marketable securities – current 1,245 50
Accounts receivable – net 3,528 3,601
Inventories 4,039 3,944
Prepaids 470 344
Other current assets 967 326
Current assets of discontinued operations — 2,379
Total current assets 16,299 16,379
Property, plant and equipment – net 7,529 7,690
Operating lease right of use assets 606 657
Goodwill and intangible assets – net 7,637 7,705
Other assets 8,804 6,806
Non-current assets of discontinued operations — 11,343
Total assets $ 40,875 $ 50,580
LIABILITIES AND EQUITY
Current liabilities
Short-term borrowings and current portion of long-term debt $ 1,870 $ 2,947
Accounts payable 2,689 2,776
Accrued payroll 703 695
Accrued income taxes 473 304
Operating lease liabilities – current 168 192
Other current liabilities 5,488 6,660
Current liabilities of discontinued operations — 1,723
Total current liabilities 11,391 15,297
Long-term debt 11,319 13,088
Other liabilities 13,471 16,641
Non-current liabilities of discontinued operations — 686
Total liabilities 36,181 45,712
Total equity 4,694 4,868
Shares outstanding
September 30, 2024: 544,558,607
December 31, 2023: 552,581,136
Total liabilities and equity $ 40,875 $ 50,580
3M Company and Subsidiaries
CONDENSED CONSOLIDATED BALANCE SHEET
(Dollars in millions)
(Unaudited)
2

-- 2 of 17 --

Nine months ended September 30,
2024 2023
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES $ 1 $ 4,694
Cash flows from investing activities:
Purchases of property, plant and equipment (890) (1,257)
Purchases and proceeds from sale or maturities of marketable
securities and investments – net (1,198) 149
Proceeds from sale of businesses, net of cash sold — 60
Other investing activities 28 142
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES (2,060) (906)
Cash flows from financing activities:
Change in debt – net 5,509 62
Purchases of treasury stock (1,096) (31)
Proceeds from issuances of treasury stock pursuant to stock option and
benefit plans 68 245
Dividends paid to shareholders (1,604) (2,483)
Cash transferred to Solventum related to separation, net (616) —
Other financing activities (83) (16)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES 2,178 (2,223)
Effect of exchange rate changes on cash and cash equivalents (2) (80)
Net increase (decrease) in cash and cash equivalents 117 1,485
Cash and cash equivalents at beginning of year 5,933 3,655
Cash and cash equivalents at end of period $ 6,050 $ 5,140
The Consolidated Statements of Cash Flows include the results of continuing and discontinued operations and, therefore, also include cash
and cash equivalents associated with Solventum through its April 2024 separation from 3M that were presented in current assets of
discontinued operations in the 3M Consolidated Balance Sheet.
3M Company and Subsidiaries
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(Dollars in millions)
(Unaudited)
3

-- 3 of 17 --

Three months ended September 30, 2024
Sales Change Analysis By Geographic Area Americas Asia Pacific Europe, Middle
East and Africa Worldwide
Organic sales 0.3 % 1.7 % (4.2) % (0.1) %
Divestitures 1.2 0.1 0.5 0.8
Translation (0.8) (0.4) 1.3 (0.3)
Total sales change 0.7 % 1.4 % (2.4) % 0.4 %
Nine months ended September 30, 2024
Sales Change Analysis By Geographic Area Americas Asia Pacific Europe, Middle
East and Africa Worldwide
Organic sales (0.3) % 1.3 % (2.5) % (0.2) %
Acquisitions 0.5 0.1 — 0.3
Divestitures 0.9 — 0.1 0.5
Translation (0.2) (2.8) 0.8 (0.8)
Total sales change 0.9 % (1.4) % (1.6) % (0.2) %
Three months ended September 30, 2024
Worldwide Sales Change By Business Segment Organic sales Acquisitions Divestitures Translation Total sales
change
Safety and Industrial 0.9 % — % — % (0.4) % 0.5 %
Transportation and Electronics (1.2) — — (0.3) (1.5)
Consumer (0.7) — — (0.5) (1.2)
Nine months ended September 30, 2024
Worldwide Sales Change By Business Segment Organic sales Acquisitions Divestitures Translation Total sales
change
Safety and Industrial 0.2 % — % — % (0.7) % (0.5) %
Transportation and Electronics — 0.8 — (1.2) (0.4)
Consumer (2.0) — — (0.6) (2.6)
3Total sales change is calculated based on reported sales results. The components of sales change include organic local-currency sales,
acquisitions, divestitures, and translation. Organic local-currency sales include both organic volume impacts (which excludes acquisition and
divestiture impacts) and selling price changes. Acquisition and divestiture impacts are measured separately for the first 12 months post-
transaction and, beginning April 2024, include the impact of commercial agreements associated with the separation of Solventum.
3M Company and Subsidiaries
SALES CHANGE ANALYSIS3
(Unaudited)
4

-- 4 of 17 --

3M discloses business segment operating income (loss) as its measure of segment profit/loss, reconciled to both total 3M
operating income (loss) and income before taxes. Business segment operating income (loss) excludes certain expenses and
income that are not allocated to business segments (as described below in “Corporate and Unallocated and Other”).
3M made certain changes to the composition of segment information reviewed by 3M's chief operating decision maker
(CODM) effective in the second quarter of 2024 largely as a result of the separation of Solventum and changes within its
business segments effective in the first quarter of 2024. Accordingly, information provided herein reflects the impact of these
changes for all applicable periods presented.
Effective in the second quarter of 2024, this change included the following:
Elimination of former Health Care business segment
• The former Health Care business segment was eliminated in the second quarter of 2024 in connection with the
separation of Solventum and reflection of its historical net income and applicable assets and liabilities included in the
Separation as discontinued operations within 3M's financial statements.
Addition of ‘Other’ and update to ‘Corporate and Unallocated’
• 3M added the “Other” category of information as a result of the Separation. It principally reflects:
◦ Transition arrangement agreements (e.g. fees charged by 3M, net of underlying costs) related to divested
businesses, including those related to the Separation, as well as other applicable divestitures.
◦ Operations of businesses of the former Health Care segment divested prior to the Separation and therefore not
reflected as discontinued operations within 3M's financial statements, along with limited-duration supply
agreements with those previous divestitures.
• Activity included in 3M’s existing “Corporate and Unallocated” was updated primarily to additionally reflect:
◦ Removal of costs related to separating and divesting Solventum that were eligible to be part of discontinued
operations.
◦ Commercial activity with Solventum post-Separation and certain operations of the former Health Care
business segment retained by 3M.
◦ Costs previously allocated to Solventum prior to the Separation that were not eligible to be part of
discontinued operations (and prospectively, post-spin, became additional costs allocated to remaining
business segments) other than those beginning in the first quarter of 2024 included in “Other” associated with
transition arrangement activity for which 3M began to charge fees in April 2024.
In addition, effective in the first quarter of 2024, 3M made certain changes within its business segments as described below.
While they impacted the composition of certain divisions within business segments, they did not change the overall
composition of segments or the measure of segment operating performance used by 3M’s CODM.
Creation of Industrial Specialties division (within Safety and Industrial business segment) and Commercial Branding and
Transportation division (within Transportation and Electronics business segment)
• 3M created the Industrial Specialties division within the Safety and Industrial business segment, which consists of the
former Closure and Masking Systems division along with certain products formerly within the Industrial Adhesive and
Tapes division and the Personal Safety division. Further, 3M created the Commercial Branding and Transportation
division within the Transportation and Electronics business segment, which consists of the former Commercial
Solutions division and the Transportation Safety division.
Re-alignment of divisions within Consumer business segment
• Within the Consumer business segment, the business re-aligned to the following four divisions: Consumer Safety and
Well-Being, Home and Auto Care, Home Improvement, and Packaging and Expression.
3M Company and Subsidiaries
BUSINESS SEGMENTS
(Unaudited)
5

-- 5 of 17 --

BUSINESS SEGMENT INFORMATION Three months ended
September 30, Nine months ended
September 30,	NET SALES
(Millions) 2024 2023 2024 2023
Safety and Industrial $ 2,767 $ 2,751 $ 8,258 $ 8,295
Transportation and Electronics 2,139 2,171 6,386 6,412
Consumer 1,299 1,315 3,702 3,800
Total reportable business segments 6,205 6,237 18,346 18,507
Corporate and Unallocated 81 26 193 71
Other 8 7 26 30
Total Company $ 6,294 $ 6,270 $ 18,565 $ 18,608
BUSINESS SEGMENT INFORMATION Three months ended
September 30, Nine months ended
September 30,	OPERATING INCOME (LOSS)
(Millions) 2024 2023 2024 2023
Safety and Industrial $ 650 $ 666 $ 1,919 $ 1,801
Transportation and Electronics 436 389 1,345 1,093
Consumer 263 269 698 683
Total reportable business segments 1,349 1,324 3,962 3,577
Corporate and Unallocated
Corporate special items:
Net costs for significant litigation (25) (4,270) (96) (14,709)
Divestiture costs — (7) (20) (11)
Gain on business divestitures — 36 — 36
Russia exit (charges) benefits — — — 18
Total corporate special items (25) (4,241) (116) (14,666)
Other corporate (expense) income - net (14) (185) (87) (524)
Total Corporate and Unallocated (39) (4,426) (203) (15,190)
Other 6 6 (22) 25
Total Company operating income (loss) 1,316 (3,096) 3,737 (11,588)
Other expense/(income), net (405) 206 (323) 334
Income (loss) before income taxes $ 1,721 $ (3,302) $ 4,060 $ (11,922)
Corporate and Unallocated and Other
Outside of 3M's reportable operating segments, 3M has Corporate and Unallocated and Other which are not reportable business
segments as they do not meet the segment reporting criteria. Because Corporate and Unallocated and Other include a variety of
miscellaneous items, they are subject to fluctuation on a quarterly and annual basis.
• Corporate and Unallocated operating income (loss) includes “corporate special items” and “other corporate expense-
net”.
◦ Corporate special items include net costs for significant litigation impacting operating income (loss)
associated with PFAS-related other environmental and Combat Arms Earplugs matters. In addition, during
the voluntary chapter 11 bankruptcy period (which began in July 2022 and ended in June 2023), costs
associated with the Aearo portion of respirator mask/asbestos matters were also included in corporate special
items. Prior to the bankruptcy, costs associated with Combat Arms Earplugs matters were not included in the
Corporate net costs for significant litigation special item, instead being reflected in the Safety and Industrial
business segment. Corporate special items for the periods presented also include divestiture costs and Russia
exit costs/ benefits. Divestiture costs include costs that were not eligible to be part of discontinued operations
related to separating and divesting substantially an entire business segment of 3M following public
announcement of its intended divestiture.
◦ Other corporate expense-net includes certain enterprise and governance activities resulting in unallocated
corporate costs and other activity and net costs that 3M may choose not to allocate directly to its business
segments. Other corporate expense-net also includes costs previously allocated to Solventum prior to the
3M Company and Subsidiaries
BUSINESS SEGMENTS - (CONTINUED)
(Unaudited)
6

-- 6 of 17 --

Separation that were not eligible to be part of discontinued operations, commercial activity with Solventum
post-Separation, and certain operations of the former Health Care business segment retained by 3M.
• Other principally reflects activity associated with:
◦ Operations of businesses of the former Health Care segment divested prior to the Separation and therefore not
reflected as discontinued operations within 3M's financial statements, along with limited-duration supply
agreements with those previous divestitures.
◦ Transition arrangement agreements (e.g. fees charged by 3M, net of underlying costs) related to divested
businesses, including those related to the Separation, as well as other applicable divestitures.
3M Company and Subsidiaries
BUSINESS SEGMENTS - (CONTINUED)
(Unaudited)
7

-- 7 of 17 --

In addition to reporting financial results in accordance with U.S. GAAP, 3M also provides certain non-GAAP measures. These
measures are not in accordance with, nor are they a substitute for GAAP measures, and may not be comparable to similarly
titled measures used by other companies.
Certain measures adjust for the impacts of special items. Special items for the periods presented include the items described in
the section entitled “Description of special items”. Because 3M provides certain information with respect to business segments,
it is noteworthy that special items impacting operating income (loss) are reflected in Corporate and Unallocated, except as
described with respect to net costs for significant litigation and manufactured PFAS products items in the “Description of
special items” section. The reconciliations below, therefore, also include impacted segments as applicable.
This document contains measures for which 3M provides the reported GAAP measure and a non-GAAP measure adjusted for
special items. The document also contains additional measures which are not defined under U.S. GAAP. These measures and
reasons 3M believes they are useful to investors (and, as applicable, used by 3M) include:
GAAP amounts for which a measure adjusted for
special items is also provided: Reasons 3M believes the measure is useful:
• Net sales (and sales change)
Considered, in addition to segment operating performance, in
evaluating and managing operations; useful in understanding
underlying business performance, provides additional transparency to
special items
• Operating income (loss), segment operating
income (loss) and operating income (loss) margin
• Other expense (income), net
• Income (loss) from continuing operations before
taxes
• Provision for income taxes and effective tax rate
• Net income (loss) from continuing operations
• Earnings (loss) per share from continuing
operations
Additional non-GAAP measures:
• Adjusted net cash provided by (used in)
operating activities; adjusted purchases of
property, plant and equipment (also referred to as
adjusted capital expenditures); adjusted free cash
flow and adjusted free cash flow conversion
Used as indicators of strength and ability to generate cash and as
indicator of capital deployment; meaningful as measures of
performance
• Adjusted EBITDA and adjusted EBITDA margin Considered in evaluating and managing operations; meaningful in
analyses of ongoing underlying operating trends
• Net debt Meaningful as indicator of liquidity and measure of capital structure
strategy
The following provides additional information and applicable GAAP amounts reconciled to non-GAAP measures.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES
(Unaudited)
8

-- 8 of 17 --

Certain amounts adjusted for special items (non-GAAP measures):
Three months ended September 30, 2023
(Dollars in millions, except per share amounts) Net sales
Operating
income
(loss)
Operating
income
(loss)
margin
Other
expense
(income),
net
Income (loss)
from continuing
operations before
taxes
Provision
(benefit)
for income
taxes Effective
tax rate
Net income (loss)
from continuing
operations
attributable to 3M
Earnings (loss)
per diluted share
from continuing
operations
Safety and Industrial
GAAP amounts $ 666 24.2 %
Adjustments for special items:
Net costs for significant litigation 42
Total special items 42
Adjusted amounts (non-GAAP measures)4 $ 708 25.7 %
Transportation and Electronics
GAAP amounts $ 2,171 $ 389 17.9 %
Adjustments for special items:
Manufactured PFAS products (292) 105
Total special items (292) 105
Adjusted amounts (non-GAAP measures)4 $ 1,879 $ 494 26.3 %
Total Company
GAAP amounts $ 6,270 $ (3,096) (49.4) % $ 206 $ (3,302) $ (777) 23.5 % $ (2,527) $ (4.56)
Adjustments for special items:
Net costs for significant litigation5 — 4,312 (157) 4,469 1,068 3,401 6.13
Manufactured PFAS products (292) 105 — 105 25 80 0.15
Gain on business divestitures — (36) — (36) (11) (25) (0.05)
Divestiture costs — 7 — 7 2 5 0.01
Total special items (292) 4,388 (157) 4,545 1,084 3,461 6.24
Adjusted amounts (non-GAAP measures)4 $ 5,978 $ 1,292 21.6 % $ 49 $ 1,243 $ 307 24.8 % $ 934 $ 1.68
Three months ended September 30, 2024
(Dollars in millions, except per share amounts) Net sales
Sales
change
Operating
income
(loss)
Operating
income
(loss)
margin
Other
expense
(income),
net
Income
(loss) from
continuing
operations
before
taxes
Provision
(benefit)
for income
taxes Effective
tax rate
Net income
(loss) from
continuing
operations
attributable
to 3M
Earnings
(loss) per
diluted
share
from
continuing
operations
Earnings
per diluted
share from
continuing
operations
percent
change
Safety and Industrial
GAAP amounts $ 650 23.5 %
Adjustments for special items:
Net costs for significant litigation 22
Total special items 22
Adjusted amounts (non-GAAP measures)4 $ 672 24.3 %
Transportation and Electronics
GAAP amounts $ 2,139 (1.5) % $ 436 20.4 %
Adjustments for special items:
Manufactured PFAS products (226) 34
Total special items (226) 34
Adjusted amounts (non-GAAP measures)4 $ 1,913 1.8 % $ 470 24.5 %
Total Company
GAAP amounts $ 6,294 0.4 % $ 1,316 20.9 % $ (405) $ 1,721 $ 348 20.3 % $ 1,372 $ 2.48 154 %
Adjustments for special items:
Net costs for significant litigation — 47 (157) 204 (75) 279 0.51
Manufactured PFAS products (226) 34 — 34 9 25 0.04
Solventum ownership - change in value — — 581 (581) — (581) (1.05)
Total special items (226) 81 424 (343) (66) (277) (0.50)
Adjusted amounts (non-GAAP measures)4 $ 6,068 1.5 % $ 1,397 23.0 % $ 19 $ 1,378 $ 282 20.5 % $ 1,095 $ 1.98 18 %
4These items represent amounts adjusted for special items. See lead-in to non-GAAP measures discussion.
5For the per share amount, this includes adjusting-out the impact of this item causing weighted average shares outstanding to be the same for
both basic and diluted loss per share in periods of resulting net losses.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES – (CONTINUED)
(Unaudited)
9

-- 9 of 17 --

Nine months ended September 30, 2023
(Dollars in millions, except per share amounts) Net sales
Operating
income
(loss)
Operating
income
(loss)
margin
Other
expense
(income),
net
Income
(loss) from
continuing
operations
before taxes
Provision
(benefit)
for income
taxes Effective
tax rate
Net income
(loss) from
continuing
operations
attributable
to 3M
Earnings
(loss) per
diluted share
from
continuing
operations
Safety and Industrial
GAAP amounts $ 1,801 21.7 %
Adjustments for special items:
Net costs for significant litigation 83
Total special items 83
Adjusted amounts (non-GAAP measures)4 $ 1,884 22.7 %
Transportation and Electronics
GAAP amounts $ 6,412 $ 1,093 17.0 %
Adjustments for special items:
Manufactured PFAS products (969) 54
Total special items (969) 54
Adjusted amounts (non-GAAP measures)4 $ 5,443 $ 1,147 21.1 %
Total Company
GAAP amounts $ 18,608 $ (11,588) (62.3) % $ 334 $ (11,922) $ (2,893) 24.3 % $ (9,036) $ (16.32)
Adjustments for special items:
Net costs for significant litigation5 — 14,792 (169) 14,961 3,532 11,429 20.64
Manufactured PFAS products (969) 54 — 54 12 42 0.08
Gain on business divestitures — (36) — (36) (11) (25) (0.05)
Russia exit charges (benefits) — (18) — (18) 3 (21) (0.04)
Divestiture costs — 11 — 11 2 9 0.02
Total special items (969) 14,803 (169) 14,972 3,538 11,434 20.65
Adjusted amounts (non-GAAP measures)4 $ 17,639 $ 3,215 18.2 % $ 165 $ 3,050 $ 645 21.2 % $ 2,398 $ 4.33
Nine months ended September 30, 2024
(Dollars in millions, except per share amounts) Net sales
Sales
change
Operating
income
(loss)
Operating
income
(loss)
margin
Other
expense
(income),
net
Income
(loss) from
continuing
operations
before
taxes
Provision
(benefit)
for
income
taxes Effective
tax rate
Net income
(loss) from
continuing
operations
attributable
to 3M
Earnings
(loss) per
diluted
share from
continuing
operations
Earnings
per diluted
share from
continuing
operations
percent
change
Safety and Industrial
GAAP amounts $ 1,919 23.2 %
Adjustments for special items:
Net costs for significant litigation 40
Total special items 40
Adjusted amounts (non-GAAP measures)4 $ 1,959 23.7 %
Transportation and Electronics
GAAP amounts $ 6,386 (0.4) % $ 1,345 21.1 %
Adjustments for special items:
Manufactured PFAS products (743) 30
Total special items (743) 30
Adjusted amounts (non-GAAP measures)4 $ 5,643 3.7 % $ 1,375 24.4 %
Total Company
GAAP amounts $ 18,565 (0.2) % $ 3,737 20.1 % $ (323) $ 4,060 $ 771 19.0 % $ 3,281 $ 5.92 136 %
Adjustments for special items:
Net costs for significant litigation — 136 (563) 699 (69) 768 1.39
Manufactured PFAS products (743) 30 — 30 7 23 0.04
Divestiture costs — 20 — 20 (111) 131 0.24
Solventum ownership - change in value — — 1,694 (1,694) — (1,694) (3.06)
Pension risk transfer charge — — (795) 795 188 607 1.09
Total special items (743) 186 336 (150) 15 (165) (0.30)
Adjusted amounts (non-GAAP measures)4 $ 17,822 1.0 % $ 3,923 22.0 % $ 13 $ 3,910 $ 786 20.1 % $ 3,116 $ 5.62 30 %
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES
(Unaudited)
10

-- 10 of 17 --

2024 forecast
2024 adjusted earnings per share from continuing operations (non-GAAP measure)4,6 $7.20 to $7.30
2024 adjusted effective tax rate (non-GAAP measure)4,6 19% to 20%
63M provides these forward-looking non-GAAP measures, but cannot, without unreasonable effort, forecast certain items to present or
provide a reconciliation to corresponding forecasted GAAP measures. These include special items such as net costs for significant
litigation; projected divestiture gains; divestiture costs; divestiture-related restructuring; changes in value of Solventum ownership; and
net sales and estimates of income and associated activity of exited manufactured PFAS products all of which are subject to limitations in
predictability of timing, ultimate outcome and numerous conditions outside of 3M’s control. 3M believes these limitations would result
in a range of projected values so broad as to not be meaningful to investors. For these reasons, 3M believes that the probable significance
of such information is low. Additionally, for similar reasons, 3M does not include the impact of potentially-divested or acquired
businesses on expected operations in forecasted outlook guidance it provides until close of a transaction. Information with respect to
special items for certain historical periods is included in the section entitled “Description of special items”.
Three months ended September 30, 2024
Sales Change3
Organic
sales Acquisitions Divestitures Translation Total sales
change
Total Company (0.1) % — % 0.8 % (0.3) % 0.4 %
Remove manufactured PFAS products special item impact 1.1 — 0.1 (0.1) 1.1
Adjusted total Company (non-GAAP measures)4 1.0 % — % 0.9 % (0.4) % 1.5 %
Transportation and Electronics (1.2) % — % — % (0.3) % (1.5) %
Remove manufactured PFAS products special item impact 3.2 — — 0.1 3.3
Adjusted Transportation and Electronics (non-GAAP measures)4 2.0 % — % — % (0.2) % 1.8 %
By Geographic Area
Americas 0.3 % — % 1.2 % (0.8) % 0.7 %
Remove manufactured PFAS products special item impact — — — — —
Adjusted Americas (non-GAAP measures)4 0.3 % — % 1.2 % (0.8) % 0.7 %
Asia Pacific 1.7 % — % 0.1 % (0.4) % 1.4 %
Remove manufactured PFAS products special item impact 2.5 — — — 2.5
Adjusted Asia Pacific (non-GAAP measures)4 4.2 % — % 0.1 % (0.4) % 3.9 %
Europe, Middle East & Africa (4.2) % — % 0.5 % 1.3 % (2.4) %
Remove manufactured PFAS products special item impact 2.4 — 0.1 — 2.5
Adjusted Europe, Middle East & Africa (non-GAAP measures)4 (1.8) % — % 0.6 % 1.3 % 0.1 %
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)
11

-- 11 of 17 --

Nine months ended September 30, 2024
Sales Change3
Organic
sales Acquisitions Divestitures Translation Total sales
change
Total Company (0.2) % 0.3 % 0.5 % (0.8) % (0.2) %
Remove manufactured PFAS products special item impact 1.2 — 0.1 (0.1) 1.2
Adjusted total Company (non-GAAP measures)4 1.0 % 0.3 % 0.6 % (0.9) % 1.0 %
Transportation and Electronics — % 0.8 % — % (1.2) % (0.4) %
Remove manufactured PFAS products special item impact 3.9 0.1 — 0.1 4.1
Adjusted Transportation and Electronics (non-GAAP measures)4 3.9 % 0.9 % — % (1.1) % 3.7 %
By Geographic Area
Americas (0.3) % 0.5 % 0.9 % (0.2) % 0.9 %
Remove manufactured PFAS products special item impact 0.4 (0.1) 0.1 — 0.4
Adjusted Americas (non-GAAP measures)4 0.1 % 0.4 % 1.0 % (0.2) % 1.3 %
Asia Pacific 1.3 % 0.1 % — % (2.8) % (1.4) %
Remove manufactured PFAS products special item impact 2.6 (0.1) 0.1 — 2.6
Adjusted Asia Pacific (non-GAAP measures)4 3.9 % — % 0.1 % (2.8) % 1.2 %
Europe, Middle East & Africa (2.5) % — % 0.1 % 0.8 % (1.6) %
Remove manufactured PFAS products special item impact 1.7 — — (0.1) 1.6
Adjusted Europe, Middle East & Africa (non-GAAP measures)4 (0.8) % — % 0.1 % 0.7 % — %
Full-Year 2024 Forecast
Sales Change3 Organic sales Acquisitions Divestitures Translation Total sales change
Total Company6 ~1% — % ~0.75% ~(0.75)% ~1%
Remove manufactured PFAS products impact6 — — — — —
Adjusted total Company (non-GAAP measures)4,6 ~1% — % ~0.75% ~(0.75)% ~1%
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)
12

-- 12 of 17 --

Adjusted net cash provided by (used in) operating activities; adjusted purchases of property, plant and equipment (also
referred to as adjusted capital expenditures); adjusted free cash flow and adjusted free cash flow conversion (non-
GAAP measures):
Three months ended
September 30, Nine months ended
September 30,
Major GAAP Cash Flow Categories (dollars in millions) 2024 2023 2024 2023
Net cash provided by (used in) operating activities $ (1,787) $ 1,910 $ 1 $ 4,694
Net cash provided by (used in) investing activities (1,204) (287) (2,060) (906)
Net cash provided by (used in) financing activities (1,085) (704) 2,178 (2,223)
Three months ended
September 30, Nine months ended
September 30,
Adjusted Free Cash Flow (non-GAAP measure) (dollars in millions) 2024 2023 2024 2023
Net cash provided by (used in) operating activities $ (1,787) $ 1,910 $ 1 $ 4,694
Adjustments for special items:
Net costs for significant litigation after-tax payment impacts 3,550 329 4,023 488
Divestiture costs after-tax payment impacts 53 100 328 217
Divestiture-related restructuring after-tax payment impacts — — 2 7
TCJA transition tax payment — — 193 126
Manufactured PFAS products impact after-tax payment impacts (38) (42) (166) (53)
Total adjustments for special items 3,565 387 4,380 785
Adjusted net cash provided by (used in) operating activities (non-GAAP measure)7 $ 1,778 $ 2,297 $ 4,381 $ 5,479
Purchases of property, plant and equipment (PPE) (246) (405) (890) (1,257)
Manufactured PFAS products impact - removing related purchases of PPE 14 38 53 117
Adjusted purchases of PPE (non-GAAP measure)7 $ (232) $ (367) $ (837) $ (1,140)
Adjusted free cash flow (non-GAAP measure)7 $ 1,546 $ 1,930 $ 3,544 $ 4,339
Net income (loss) attributable to 3M $ 1,372 $ (2,075) $ 3,445 $ (7,940)
Adjustments for special items, net of tax:
Net costs for significant litigation 279 3,401 768 11,429
Manufactured PFAS products impact 25 80 23 42
Gain on business divestitures — (25) — (25)
Russia exit charges (benefits) — — — (21)
Divestiture costs — 106 341 293
Solventum ownership - change in value (581) — (1,694) —
Pension risk transfer charge — — 607 —
Total adjustments for special items, net of tax (277) 3,562 45 11,718
Net income (loss) attributable to 3M adjusted for special items
(used for adjusted free cash flow calculation)
$ 1,095 $ 1,487 $ 3,490 $ 3,778
Adjusted free cash flow conversion (non-GAAP measure)7 141 % 130 % 102 % 115 %
73M’s Consolidated Statements of Cash Flows include the results of continuing and discontinued operations (Solventum separated from 3M
in April 2024); accordingly, amounts associated with the determination of adjusted free cash flow include both continuing and discontinued
operations in certain periods both from an income and cash flow perspective. 3M defines adjusted net cash provided by (used in) operating
activities as net cash provided by operating activities, adjusted for special items. 3M defines adjusted purchases of property, plant and
equipment (also referred to as adjusted capital expenditures) as purchases of property, plant and equipment (PPE) adjusted for the estimated
impact of such purchases associated with manufactured PFAS products activity. 3M defines adjusted free cash flow as adjusted net cash
provided by (used in) operating activities less adjusted purchases of PPE. Cash payments/receipts associated with special items in the
determination of adjusted net cash provided by (used in) operating activities are reflected net of applicable tax. The cash tax impact for the
portion of payments of costs for significant litigation under the 2023 settlement agreements relative to Combat Arms Earplugs and relative to
public water systems regarding PFAS is based on the timing/amount of the actual cash tax deduction (which differs from the timing of the
pre-tax settlement payments). The impacts of certain tax-related divestiture costs are based on applicable tax rates and the timing of tax
payments relative to underlying Separation transactions. For other special items, the cash tax impact is estimated using the U.S. statutory
corporate tax rate during the period of payment/receipt. Tax impacts include associated impacts on Foreign Derived Intangible Income (FDII),
Global Intangible Low Taxed Income (GILTI), foreign tax credits, and tax costs of repatriation. 3M defines adjusted free cash flow
conversion as adjusted free cash flow divided by net income (loss) attributable to 3M, adjusted for special items (used for adjusted free cash
flow calculation).
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)
13

-- 13 of 17 --

Adjusted EBITDA and adjusted EBITDA margin (non-GAAP measures):
Adjusted EBITDA (non-GAAP measure)8 Adjusted EBITDA margin (non-GAAP measure)8
Three months ended
September 30, Nine months ended
September 30, Three months ended
September 30, Nine months ended
September 30,
(Dollars in millions) 2024 2023 2024 2023 2024 2023 2024 2023
Safety and Industrial $ 822 $ 826 $ 2,381 $ 2,268 29.7 % 30.0 % 28.8 % 27.3 %
Transportation and Electronics 554 570 1,626 1,377 29.0 % 30.3 % 28.8 % 25.3 %
Consumer 302 316 814 806 23.2 % 24.0 % 22.0 % 21.2 %
Corporate and Unallocated and
Other 4 (93) (74) (331)
Total Company $ 1,682 $ 1,619 $ 4,747 $ 4,120 27.7 % 27.1 % 26.6 % 23.4 %
Three months ended
September 30,
Nine months ended
September 30,
Adjusted EBITDA (non-GAAP measure) (dollars in millions) 2024 2023 2024 2023
Adjusted net sales (non-GAAP measure)4 $ 6,068 $ 5,978 $ 17,822 $ 17,639
Net income (loss) from continuing operations attributable to 3M 1,372 (2,527) 3,281 (9,036)
Add/(subtract):
Net income/(loss) attributable to noncontrolling interest 4 4 15 14
(Income)/loss from unconsolidated subsidiaries, net of taxes (3) (2) (7) (7)
Provision for income taxes 348 (777) 771 (2,893)
Other expense/(income):
Interest (Income)/expense 169 232 579 411
Pension & OPEB non-service cost (benefit) 7 (26) 792 (77)
Solventum ownership - change in value (581) — (1,694) —
Depreciation and amortization (DA) expense 310 396 902 1,034
Adjustments for special items:
Net costs for significant litigation 47 4,312 136 14,792
Manufactured PFAS products impact:
Remove manufactured PFAS products operating (income) loss 34 105 30 54
Subtract PFAS-related amount included in DA above (25) (69) (78) (129)
Gain on business divestitures — (36) — (36)
Russia exit charges (benefits) — — — (18)
Divestiture costs — 7 20 11
Total special items 56 4,319 108 14,674
Adjusted EBITDA (non-GAAP measure)8 $ 1,682 $ 1,619 $ 4,747 $ 4,120
Adjusted EBITDA margin (non-GAAP measure)8 27.7 % 27.1 % 26.6 % 23.4 %
83M defines adjusted EBITDA as net income (loss) from continuing operations attributable to 3M, adjusted for net income/(loss) attributable
to noncontrolling interest,(income)/loss from unconsolidated subsidiaries, provision for income taxes, other expense/(income), depreciation
and amortization expense, and special items. For business segments, 3M defines adjusted EBITDA as business segment operating income
(loss) (3M’s measure of segment operating performance) adjusted for special items that is then further adjusted for depreciation and
amortization (DA) expense, net of the PFAS-related amount included in DA. The Company defines adjusted EBITDA margin as adjusted
EBITDA divided by net sales, adjusted for special items.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)
14

-- 14 of 17 --

Adjusted EBITDA (non-GAAP measure)
Three months ended September 30, 2024 (dollars in millions) Safety and
Industrial
Transportation
and
Electronics Consumer
Corporate
and
Unallocated
and Other Total
Company
Adjusted net sales (non-GAAP measure)4 $ 2,767 $ 1,913 $ 1,299 $ 89 $ 6,068
Business segment operating income (loss) (measure of
segment operating performance), adjusted for special
items (non-GAAP measure)4 $ 672 $ 470 $ 263 $ (8) $ 1,397
Add/(subtract):
Add depreciation and amortization (DA) expense 150 109 39 12 310
Subtract PFAS-related amount included in DA above — (25) — — (25)
Adjusted EBITDA (non-GAAP measure)8 $ 822 $ 554 $ 302 $ 4 $ 1,682
Adjusted EBITDA margin (non-GAAP measure)8 29.7 % 29.0 % 23.2 % 27.7 %
Three months ended September 30, 2023 (dollars in millions)
Adjusted net sales (non-GAAP measure)4 $ 2,751 $ 1,879 $ 1,315 $ 33 $ 5,978
Business segment operating income (loss) (measure of
segment operating performance), adjusted for special
items (non-GAAP measure)4 $ 708 $ 494 $ 269 $ (179) $ 1,292
Add/(subtract):
Add depreciation and amortization (DA) expense 118 145 47 86 396
Subtract PFAS-related amount included in DA above — (69) — — (69)
Adjusted EBITDA (non-GAAP measure)8 $ 826 $ 570 $ 316 $ (93) $ 1,619
Adjusted EBITDA margin (non-GAAP measure)8 30.0 % 30.3 % 24.0 % 27.1 %
Nine months ended September 30, 2024 (dollars in millions)
Adjusted net sales (non-GAAP measure)4 $ 8,258 $ 5,643 $ 3,702 $ 219 $ 17,822
Business segment operating income (loss) (measure of
segment operating performance), adjusted for special
items (non-GAAP measure)4 $ 1,959 $ 1,375 $ 698 $ (109) $ 3,923
Add/(subtract):
Add depreciation and amortization (DA) expense 422 329 116 35 902
Subtract PFAS-related amount included in DA above — (78) — — (78)
Adjusted EBITDA (non-GAAP measure)8 $ 2,381 $ 1,626 $ 814 $ (74) $ 4,747
Adjusted EBITDA margin (non-GAAP measure)8 28.8 % 28.8 % 22.0 % 26.6 %
Nine months ended September 30, 2023 (dollars in millions)
Adjusted net sales (non-GAAP measure)4 $ 8,295 $ 5,443 $ 3,800 $ 101 $ 17,639
Business segment operating income (measure of
segment operating performance), adjusted for special
items (non-GAAP measure)4 $ 1,884 $ 1,147 $ 683 $ (499) $ 3,215
Add/(subtract):
Add depreciation and amortization (DA) expense 384 359 123 168 1,034
Subtract PFAS-related amount included in DA above — (129) — — (129)
Adjusted EBITDA (non-GAAP measure)8 $ 2,268 $ 1,377 $ 806 $ (331) $ 4,120
Adjusted EBITDA margin (non-GAAP measure)8 27.3 % 25.3 % 21.2 % 23.4 %
Net debt (non-GAAP measure):
Net Debt (non-GAAP measure) September 30, 2024 December 31, 2023
Total debt $ 13,189 $ 16,035
Less: Cash, cash equivalents and marketable securities 7,315 5,805
Net debt (non-GAAP measure)9 $ 5,874 $ 10,230
9The Company defines net debt as total debt less the total of cash, cash equivalents and current and long-term marketable securities all on a
continuing operations basis.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)
15

-- 15 of 17 --

Description of special items:
In addition to reporting financial results in accordance with U.S. GAAP, the Company also provides various non-GAAP
measures that incorporate adjustments for the impacts of special items. Special items incorporated in the preparation of these
non-GAAP measures for the periods presented include the items described below:
Net costs for significant litigation:
• These relate to 3M's respirator mask/asbestos (which include Aearo and non-Aearo items), PFAS-related other
environmental, and Combat Arms Earplugs matters. Net costs include the impacts of changes in accrued liabilities
(including interest imputation on applicable settlement obligations), external legal fees, and insurance recoveries, along
with the associated tax impacts. Associated tax impacts of significant litigation include impacts on Foreign Derived
Intangible Income (FDII), Global Intangible Low Taxed Income (GILTI), foreign tax credits and tax costs of
repatriation. 3M does not consider the elements of the net costs associated with these matters to be normal, operating
expenses related to the Company’s ongoing operations, revenue generating activities, business strategy, industry, and
regulatory environment. Net costs related to respirator mask/asbestos are reflected as special items in the Safety and
Industrial business segment while those impacting operating income (loss) associated with PFAS-related other
environmental and Combat Arms Earplugs matters are reflected as corporate special items in Corporate and Unallocated.
In addition, during the voluntary chapter 11 bankruptcy period (which began in July 2022 and ended in June 2023), costs
associated with the Aearo portion of respirator mask/asbestos matters were reflected in corporate special items in
Corporate and Unallocated. Prior to the bankruptcy, costs associated with Combat Arms Earplugs matters were reflected
as part of special items in the Safety and Industrial business segment. In the third quarter of 2024 and 2023, 3M reflected
net pre-tax payments of approximately $3.7 billion and $416 million, respectively, related to net costs for significant
litigation. In the first nine months of 2024 and 2023, 3M made net pre-tax payments of approximately $4.5 billion and
$618 million, respectively, related to net costs for significant litigation.
Divestiture costs:
• These include certain limited costs that were not eligible to be included within discontinued operations related to
separating and divesting substantially an entire business segment of 3M following public announcement of its intended
divestiture. As a result of completion of the April 2024 separation of Solventum, this includes the tax cost of update to
3M’s previous indefinite reinvestment plans on past unrepatriated earnings through the period of the Separation’s close
and to tax positions retained by 3M. 3M’s statement of cash flows includes the results of both continuing and
discontinued operations. Therefore, in the context of amounts used in the determination of non-GAAP measures
associated with cash flow and adjusted free cash flow conversion, this special item further includes the broader extent of
such costs that included within discontinued operations, including interest expense on debt issued by Solventum for the
period outstanding prior to the April 1, 2024 completion of the separation of Solventum from 3M and net tax costs of
entity structuring associated with the separation of Solventum. In the third quarter of 2024 and 2023, 3M made pre-tax
payments of approximately $25 million and $127 million, respectively, associated with divestiture costs. In the first nine
months of 2024 and 2023, 3M made pre-tax payments of approximately $217 million and $275 million, respectively,
associated with divestiture costs.
Gain on business divestitures:
• In the third quarter of 2023, 3M recorded a gain related to the sale of its dental local anesthetic business partially offset
by a loss associated with a previously contingent indemnification obligation from a 2020 divestiture.
• In 2022, 3M recorded a gain related to the split-off and combination of its Food Safety business with Neogen
Corporation.
Russia exit charges/benefits:
• In the second quarter of 2023, 3M recorded a gain on final disposal of net assets in Russia. Previously, in the third
quarter of 2022, 3M recorded a charge primarily related to impairment of these assets in connection with management's
committed exit and disposal plan.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)
16

-- 16 of 17 --

Divestiture-related restructuring actions:
• In the third quarter of 2022, following the split-off of the Food Safety business, management approved and committed to
undertake certain restructuring actions addressing corporate functional costs across 3M in relation to the magnitude of
amounts previously allocated to the divested business. In the third quarter of 2023, 3M made pre-tax payments of
approximately $1 million associated with divestiture-related restructuring actions. In the first nine months of 2024 and
2023, 3M made pre-tax payments of approximately $2 million and $9 million, respectively, associated with divestiture-
related restructuring actions.
Enactment/measurement period adjustments related to the Tax Cuts and Jobs Act (TCJA):
• In the first nine months of 2024 and 2023, 3M made payments of approximately $193 million and $126 million,
respectively, related to the transition tax expense incurred as a result of the 2017 enactment of the TCJA.
Manufactured PFAS products:
• These amounts relate to sales and estimates of income (loss) and associated activity regarding manufactured PFAS
products that 3M plans to exit by the end of 2025 included within the Transportation and Electronics business segment.
Estimated income does not contemplate impacts on non-operating items such as net interest income/expense and the non-
service cost components portion of defined benefit plan net periodic benefit costs. Relative to the impact of the activity
of manufactured PFAS products on cash provided by (used in) operating activities, amounts are based on estimates of
associated income, depreciation/amortization, certain changes in working capital and accruals, and timing of associated
payments.
Pension risk transfer charge:
• In the second quarter of 2024, 3M recorded a non-cash pension settlement charge reflected in other expense (income),
net as a result of transferring a portion of its U.S. pension payment obligations and related plan assets to an insurance
company.
Solventum ownership - change in value:
• This amount relates to the change in value of 3M's retained ownership interest in Solventum common stock reflected in
other expense (income), net.
3M Company and Subsidiaries
SUPPLEMENTAL FINANCIAL INFORMATION
NON-GAAP MEASURES (CONTINUED)
(Unaudited)
17

-- 17 of 17 --